Centers for Disease Control and Prevention. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children. Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2010;59:258-261.
2.
PilishviliTLexauCFarleyMM; Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32-41.
3.
ThigpenMCWhitneyCGMessonnierNE; Emerging Infections Programs Network. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364:2016-2025.
4.
StockmannCAmpofoKByingtonCL. Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics. 2013;132:421-428.
5.
KaplanSLMasonEOJrBarsonWJ. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 1998;102:538-545.
6.
RajasinghamCRBonsuBKChapmanJICohenDMBarsonWJ. Serious neurologic sequelae in cases of meningitis arising from infection by conjugate vaccine-related and nonvaccine-related serogroups of Streptococcus pneumoniae. Pediatr Infect Dis J. 2008;27:771-775.
7.
TamPYMadoffLCCoombesBPeltonSI. Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine. Pediatrics. 2014;134:210-217.
8.
KaplanSLBarsonWJLinPL. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013;32:203-207.
9.
GuevaraMEzpeletaCGil-SetasA; Working Group for Surveillance of the Pneumococcal Disease in Navarre. Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013. Vaccine. 2014;32:2553-2562.
10.
OlarteLBarsonWJBarsonRM. Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in U.S. children. Clin Infect Dis. 2015;61:767-775.
11.
FarnhamACZimmermanCMPapadoukaV. Invasive pneumococcal disease following the introduction of 13-valent conjugate vaccine in children in New York City from 2007 to 2012. JAMA Pediatr. 2015;169:646-652.
12.
HarboeZBThomsenRWRiisA. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med. 2009;6:e1000081.
13.
de JongeRCvan FurthAMWassenaarMGemkeRJTerweeCB. Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infect Dis. 2010;10:232.
